期刊文献+

^(32)P治疗真性红细胞增多症的临床回顾

下载PDF
导出
机构地区 华东医院血液科
出处 《老年医学与保健》 CAS 2006年第3期180-181,共2页 Geriatrics & Health Care
  • 相关文献

参考文献12

  • 1单渊东,张之南.真性红细胞增多症.协和血液病学.中国协和医科大学出版社,2004,341~348.
  • 2辛沈,边瓯,贺顺川,林朝胜,刘丽梅.老年真性红细胞增多症18例临床分析[J].实用老年医学,2005,19(1):55-55. 被引量:4
  • 3白洁,邵宗鸿.真性红细胞增多症造血干及祖细胞生物学特征的研究进展[J].中华内科杂志,2002,41(2):140-142. 被引量:14
  • 4白洁,邵宗鸿,井丽萍,刘鸿,施均,赵明峰,付蓉,何广胜,孙娟,贾海蓉,钱林生,杨天楹,杨崇礼.185例真性红细胞增多症的临床分析[J].中华血液学杂志,2002,23(11):578-580. 被引量:28
  • 5单渊东,刘尔坤.真性红细胞增多症的转化[J].中华内科杂志,1990,29(1):19-21. 被引量:3
  • 6Gruppo Italiano Studio Policitemia.Polycythemia Vera:The Natural History of 1213 Patients Followed for 20 Years.Annals of Internal Medicine.November,1995,9(123):657~663.
  • 7Berk PD,Goldberg JD,Silverstein MN,et al.Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.The New England Journal of Medicine,1981,8(304):441~447.
  • 8Berk PD,Goldberg JD,Donovan PB,et al.Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.Semin Hematol,1986,23:132~143.
  • 9Najean Y,Dresch C,Rain JD.The very-long-term course of polycythemia:a complement to to the previously published data of the Polycythemia Vera Study Group.Br J Haematol,1994,86:233~235.
  • 10Tartaglia AP,Goldberg JD,Berk PD,et al.Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.Semin Hematol,1986,23:172~176.

二级参考文献23

  • 1陈玉梅.重组α-干扰素与真性红细胞增多症.国外医学:输血及血液学分册,1995,18(5):316-316.
  • 2刘尔坤,中华内科杂志,1984年,23卷,416页
  • 3Kralovics R,Indrak K,Stopka T, et al. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood, 1997,90:2057-2061.
  • 4Chiba S, Takahashi T, Takeshita K, et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood, 1997, 90:97-104.
  • 5Le Couedic JP, Mitjavila MT, Villeval JL, et al. Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood, 1996, 87:1502-1511.
  • 6Yan XQ, Lacey D, Fletcher F,et al. Chronic expossure to retroviral vector encoded MGDF(mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood, 1995, 86:4025-4033.
  • 7Kieran MW, Perkins AC, Orkin SH, et al. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA, 1996, 93:9126-9131.
  • 8Ratajczak MZ, Ratajczak J, Marlicz W, et al. Recombinant human thrombopoietin(TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis. Br J Haematol, 1997,98:8-18.
  • 9Moliterno AR, Hankins, WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med, 1998,338:572-580.
  • 10Moliterno AR, Spivak JL. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood,1999,94:2555-2561.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部